MIA
EW icon

MainStreet Investment Advisors’s Edwards Lifesciences EW Stock Holding History

MainStreet Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,560
Closed -$287K – 258
2020
Q1 		$287K Buy
4,560
+1,398
+44% +$101K 0.04% 210
2019
Q4 		$245K Hold
3,162
– – 0.03% 170
2019
Q3 		$231K Buy
+3,162
New +$222K 0.03% 156

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

MainStreet Investment Advisors's EW Position: Q2 2020 in Review

MainStreet Investment Advisors sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 4,560 shares — an estimated $287K sold.

MainStreet Investment Advisors first reported a position in EW in Q3 2019 and held it in 3 quarters. The position peaked at $287K in Q1 2020. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • MainStreet Investment Advisors reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • MainStreet Investment Advisors sold 4,560 Edwards Lifesciences shares in Q2 2020, an estimated $287K.
  • MainStreet Investment Advisors first reported a position in Edwards Lifesciences in Q3 2019 and held it in 3 quarters.
  • MainStreet Investment Advisors's Edwards Lifesciences position peaked at $287K in Q1 2020.
  • 1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on MainStreet Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.